# Tombot

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tombot

- Industry: Healthcare IT
- Headquarters: Valencia, US
- Website: www.tombot.com
- Total disclosed funding: $13M
- Latest round: Series A (Jun 24, 2026)
- Investors on record: 7

## About

Tombot, Inc. specializes in creating robotic emotional support animals, enhancing the well-being of individuals, especially the elderly, through innovative technology that combats loneliness and provides companionship.Founded in 2017 in California, US, Tombot, Inc. develops robotic therapy animals, including its flagship product, Jennie. The company was co-founded by Tom Stevens (CEO), Hank Schorz (CTO), Jesse Schorz (COO). In June 2026, Tombot, Inc. raised USD 7 million in series A funding from Florida Community Health Network, Lutheran Foundation, Caduceus Capital Partners, and Wavemaker Three-Sixty Health. Tombot, Inc. specializes in the development and sale of robotic emotional support animals, notably their flagship product, Jennie, a robotic therapy dog designed to provide companionship and alleviate feelings of loneliness in individuals, particularly the elderly and those in memory care facilities. These robotic pets simulate the experience of having a live pet, offering a solution for users who cannot care for traditional pets due to health conditions or living arrangements. The primary clientele includes nursing homes, assisted living facilities, and direct consumers who seek emotional support for personal health challenges, such as dementia or anxiety disorders. The company targets markets in North America and Europe, focusing on regions with a high demand for innovative care solutions that cater to the emotional and mental well-being of aging populations.Tombot's revenue model is centered around direct-to-consumer sales and partnerships with healthcare facilities. Clients typically purchase the robotic animals outright, with a minimum investment requirement for larger-scale partnerships potentially being waived at the company's discretion. The average transaction involves clients purchasing the robotic dogs, with pricing reflecting the advanced technology and emotional support capabilities embedded within the products. By positioning itself in both the consumer and B2B markets, Tombot aims to foster relationships with healthcare providers who see value in integrating robotic pets into their care programs, thus enhancing the emotional health of their residents while providing a unique offering that addresses both companionship and therapeutic needs. The company plans to utilize the June 2026 funding to increase production capacity, prepare for the launch of its robotic companion product, and support the development of additional companion robotics offerings.

## Funding rounds

- Series A, Jun 24, 2026, $7M — Lutheran Foundation, Wavemaker Three-Sixty Health, Caduceus Capital Partners, Florida Community Health Network
- Series A, Jun 12, 2025, $6.1M — Caduceus Capital Partners
- Seed, Aug 1, 2021 — Start Engine, Wavemaker Three-Sixty Health, 32 Ventures, Angel Physicians Fund

## Investors

- Start Engine — Seed
- Wavemaker Three-Sixty Health (https://capitalatlas.ai/funds/wavemaker-three-sixty-health) — Seed, Series A
- 32 Ventures — Seed
- Angel Physicians Fund (https://capitalatlas.ai/funds/angel-physicians-fund) — Seed
- Caduceus Capital Partners (https://capitalatlas.ai/funds/caduceus-capital-partners) — Series A
- Lutheran Foundation — Series A
- Florida Community Health Network — Series A